Sitagliptin Tablets 50 Mg

Sitagliptin Tablets 50 Mg

Sitagliptin Tablets 50 Mg is an oral anti-diabetic medication used for the management of type 2 diabetes mellitus. It belongs to the class of DPP-4 (dipeptidyl peptidase-4) inhibitors, which help regulate blood sugar levels by increasing insulin release and decreasing glucose production. This dose is commonly prescribed for patients with moderate kidney function or as part of combination therapy. It is effective when used along with diet and exercise. In diabetes care, combination therapies like Sitagliptin & Metformin Tablets 50/500 Mg and insulin options such as Tresiba Flextouch Pen are also used depending on patient needs.

Mechanism of Action

DPP-4 Inhibition

Sitagliptin works by inhibiting the DPP-4 enzyme, increasing incretin hormone levels in the body.

Blood Sugar Control

This leads to enhanced insulin secretion and reduced glucose production, especially after meals. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Sitagliptin Information.

Medical Uses

Sitagliptin Tablets 50 Mg is used for:

• Type 2 diabetes mellitus
• Blood sugar control
• Combination therapy with other antidiabetic medications

It is commonly prescribed for long-term diabetes management.

Dosage and Administration

Sitagliptin Tablets 50 Mg is usually taken once daily, with or without food, as directed by a healthcare provider. The dose may be adjusted based on kidney function and patient response. In clinical practice, Sitagliptin & Metformin Tablets 50/500 Mg is used for combination therapy, while Tresiba Flextouch Pen is prescribed when insulin support is required.

Clinical Effectiveness

Clinical studies show that sitagliptin effectively lowers blood sugar levels and improves overall glycemic control when used consistently.

Safety and Side Effects

Common Side Effects

• Headache
• Upper respiratory symptoms
• Nasal congestion

Serious Risks

• Pancreatitis (rare)
• Severe allergic reactions

Regular monitoring is recommended. For more details, refer to Mayo Clinic – Sitagliptin Information.

Contraindications and Precautions

Sitagliptin Tablets 50 Mg should be used with caution in:

• Patients with kidney disease
• Individuals with a history of pancreatitis
• Pregnant or breastfeeding women

Consult a healthcare provider before use.

Drug Interactions

Sitagliptin may interact with other antidiabetic medications, increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs